Szela Mary T.

Insider Reports History

Location
San Diego, CA
Signature
/s/ Mary Szela
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Szela Mary T.:

Company Role Class Num Shares Value Price $ Report Date Ownership
TriSalus Life Sciences, Inc. CEO and President, Director Common Stock 773,289 $3,170,484 $4.10 23 Feb 2026 Direct
TriSalus Life Sciences, Inc. CEO and President, Director Employee Stock Option (right to buy) 1,578,182 24 Nov 2025 Direct
Absci Corp Director Stock Option (right to buy) 178,400 07 Jul 2025 Direct
Kura Oncology, Inc. Director Option to purchase common stock 28,500 05 Jun 2025 Direct
Kura Oncology, Inc. Director Option to purchase common stock 26,000 05 Jun 2024 Direct
Omega Therapeutics, Inc. Director Stock Option (Right to Buy) 25,000 20 Jun 2024 Direct
Prometheus Biosciences, Inc. Director Common Stock 0 $108.42 16 Jun 2023 Direct
Prometheus Biosciences, Inc. Director Stock Option (right to buy) 0 16 Jun 2023 Direct

Insider Reports Filed by Szela Mary T.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TLSI TriSalus Life Sciences, Inc. 23 Feb 2026 1 +$124,997 4 CEO and President, Director 23 Feb 2026, 16:08
/report/000121390026018083-szela-mary-t-2026-02-18 Averin Capital Acquisition Corp. 18 Feb 2026 0 $0 3 Director 18 Feb 2026, 18:08
ABSI Absci Corp 07 Jul 2025 1 $0 4 Director 09 Jul 2025, 16:46
ABSI Absci Corp 07 Jul 2025 0 $0 3 Director 09 Jul 2025, 16:43
KURA Kura Oncology, Inc. 05 Jun 2025 1 $0 4 Director 06 Jun 2025, 16:05
TLSI TriSalus Life Sciences, Inc. 18 Feb 2025 1 $0 4 CEO AND PRESIDENT, Director 19 Feb 2025, 17:41
TLSI TriSalus Life Sciences, Inc. 29 Jan 2025 2 +$51,754 4 CEO AND PRESIDENT, Director 31 Jan 2025, 17:54
TLSI TriSalus Life Sciences, Inc. 27 Jan 2025 4 +$50,303 4 CEO AND PRESIDENT, Director 29 Jan 2025, 18:15
TLSI TriSalus Life Sciences, Inc. 12 Sep 2024 3 +$75,359 4 CEO AND PRESIDENT, Director 13 Sep 2024, 17:43
TLSI TriSalus Life Sciences, Inc. 10 Sep 2024 1 +$24,850 4 CEO AND PRESIDENT, Director 12 Sep 2024, 19:06
OMGAQ Omega Therapeutics, Inc. 20 Jun 2024 1 $0 4 Director 21 Jun 2024, 16:20
KURA Kura Oncology, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:30
TLSI TriSalus Life Sciences, Inc. 13 Feb 2024 4 $0 4 CEO and President, Director 25 Nov 2025, 15:55
TLSI TriSalus Life Sciences, Inc. 13 Feb 2024 2 $0 4 CEO AND PRESIDENT, Director 14 Feb 2024, 18:44
TLSI TriSalus Life Sciences, Inc. 14 Aug 2023 1 $0 4 CEO and President, Director 15 Aug 2023, 16:48
TLSI TriSalus Life Sciences, Inc. 10 Aug 2023 0 $0 3 CEO and President, Director 15 Aug 2023, 16:46
/report/000089924323015755-szela-mary-t-2023-06-16 Prometheus Biosciences, Inc. 16 Jun 2023 3 $0 4 Director 16 Jun 2023, 16:00
OMGAQ Omega Therapeutics, Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:05
KURA Kura Oncology, Inc. 31 May 2023 1 $0 4 Director 02 Jun 2023, 17:02
/report/000120919123031193-szela-mary-t-2023-05-19 Prometheus Biosciences, Inc. 19 May 2023 1 $0 4 Director 19 May 2023, 17:47
KURA Kura Oncology, Inc. 21 Jun 2022 1 $0 4 Director 23 Jun 2022, 16:49
OMGAQ Omega Therapeutics, Inc. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:10
/report/000120919122031178-szela-mary-t-2022-05-19 Prometheus Biosciences, Inc. 19 May 2022 1 $0 4 Director 20 May 2022, 19:30
OMGAQ Omega Therapeutics, Inc. 29 Jul 2021 0 $0 3 Director 29 Jul 2021, 21:01
KURA Kura Oncology, Inc. 22 Jun 2021 1 $0 4 Director 23 Jun 2021, 17:19